Intellia Therapeutics Inc (NTLA)
14.55
-0.10
(-0.68%)
USD |
NASDAQ |
Dec 04, 14:07
Intellia Therapeutics Price to Book Value: 1.539 for Dec. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| December 03, 2024 | 1.55 |
| December 02, 2024 | 1.664 |
| November 29, 2024 | 1.653 |
| November 27, 2024 | 1.609 |
| November 26, 2024 | 1.558 |
| November 25, 2024 | 1.565 |
| November 22, 2024 | 1.513 |
| November 21, 2024 | 1.460 |
| November 20, 2024 | 1.388 |
| November 19, 2024 | 1.495 |
| November 18, 2024 | 1.499 |
| November 15, 2024 | 1.478 |
| November 14, 2024 | 1.600 |
| November 13, 2024 | 1.704 |
| November 12, 2024 | 1.762 |
| November 11, 2024 | 1.852 |
| November 08, 2024 | 1.770 |
| November 07, 2024 | 1.693 |
| November 06, 2024 | 1.699 |
| November 05, 2024 | 1.633 |
| November 04, 2024 | 1.602 |
| November 01, 2024 | 1.567 |
| October 31, 2024 | 1.504 |
| October 30, 2024 | 1.515 |
| October 29, 2024 | 1.585 |
| Date | Value |
|---|---|
| October 28, 2024 | 1.728 |
| October 25, 2024 | 1.687 |
| October 24, 2024 | 1.676 |
| October 23, 2024 | 2.109 |
| October 22, 2024 | 2.229 |
| October 21, 2024 | 2.186 |
| October 18, 2024 | 2.229 |
| October 17, 2024 | 2.219 |
| October 16, 2024 | 2.176 |
| October 15, 2024 | 2.064 |
| October 14, 2024 | 2.063 |
| October 11, 2024 | 1.965 |
| October 10, 2024 | 1.881 |
| October 09, 2024 | 1.866 |
| October 08, 2024 | 1.892 |
| October 07, 2024 | 1.887 |
| October 04, 2024 | 1.902 |
| October 03, 2024 | 1.866 |
| October 02, 2024 | 1.962 |
| October 01, 2024 | 2.030 |
| September 30, 2024 | 2.173 |
| September 27, 2024 | 2.197 |
| September 26, 2024 | 2.152 |
| September 25, 2024 | 2.165 |
| September 24, 2024 | 2.246 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.388
Minimum
Nov 20 2024
26.25
Maximum
Sep 03 2021
5.312
Average
3.468
Median
Jul 21 2023
Price to Book Value Benchmarks
| BridgeBio Pharma Inc | -- |
| Alnylam Pharmaceuticals Inc | 1012.78 |
| Ionis Pharmaceuticals Inc | 8.684 |
| Pfizer Inc | 1.550 |
| Regeneron Pharmaceuticals Inc | 2.804 |
Price to Book Value Related Metrics
| PS Ratio | 32.41 |
| PEG Ratio | -1.590 |
| Price | 14.55 |
| Earnings Yield | -37.39% |
| Market Cap | 1.482B |
| PEGY Ratio | -1.590 |